Allergy and Immunology, Allergy · Novi, MI
NPI
1710335716
Since 2016
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
39595 W 10 Mile Rd, Ste 111
Novi, MI, 48375
Phone (248) 346-2945
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
1,640 services
Medicare patients, 2024
31
Average age 65
Drug cost, 2024
$2.2M
327 prescriptions
Company payments, 2025
$2,188
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jasmine Alsukhon was code 95004 (test - miscellaneous), 1,107 times for 19 patients. In total Jasmine Alsukhon billed 1,640 services in 15 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,107 | 19 | $2.86 | $3,168 |
| 99214 Office E&M - Established | Office | 36 | 18 | $95.50 | $3,438 |
| 99204 Office E&M - New | Office | 23 | 23 | $125.78 | $2,893 |
By year: 2022 $5,680 for 403 services; 2023 $9,164 for 1,052 services; 2024 $12K for 1,640 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jasmine Alsukhon prescribed most often to Medicare patients was Fluticasone Propionate, with 66 prescriptions and refills. In total Jasmine Alsukhon wrote 327 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 66 | 103 | 26 | $1,065 |
| Famotidine Generic | 30 | 64 | Under 11 | $450 |
| Ipratropium Bromide Generic | 26 | 30 | Under 11 | $1,049 |
| Azelastine Hcl Generic | 25 | 43 | Under 11 | $641 |
| Hydroxyzine Hcl Generic | 17 | 20 | Under 11 | $157 |
| Firazyr Icatibant Acetate | 15 | 15 | Under 11 | $1.0M |
| Orladeyo Berotralstat Hydrochloride | 13 | 13 | Under 11 | $535K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 13 | 28 | Under 11 | $17K |
| Takhzyro Lanadelumab-Flyo | 11 | 11 | Under 11 | $580K |
Brand drugs: 89 claims; generic drugs: 238 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jasmine Alsukhon $2,188 ($2,188 in general payments such as food, travel and fees) from 17 companies. The largest payer was Genzyme Corporation with $528.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 18 | $528 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $353 |
| CSL Behring CSL.AX | 9 | $322 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 11 | $218 |
| GlaxoSmithKline, LLC. GSK | 11 | $163 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $95.48 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $79.37 |
| Genentech USA, Inc. ROG.SW | 3 | $78.67 |
| ADMA BioManufacturing LLC | 1 | $51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.